Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients with Newly Diagnosed FLT3-Mutant Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Al-Kali, Aref [1 ]
Jones, Dan [1 ]
Cortes, Jorge [1 ]
Faderl, Stefan [1 ]
Ao, Xue [1 ]
Garcia-Manero, Guillermo [1 ]
Borthakur, Gautam [1 ]
Konopleva, Marina [1 ]
Brandt, Mark [1 ]
Andreeff, Michael [1 ]
Kantarjian, Hagop [1 ]
Ravandi, Farhad [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：820 / 821
页数：2
相关论文
共 50 条
  • [31] Molecular Characterization of Clinical Response and Relapse in Patients with IDH1-Mutant Newly Diagnosed Acute Myeloid Leukemia Treated with Ivosidenib and Azacitidine
    Daigle, Scott R.
    Choe, Sung
    DiNardo, Courtney D.
    Stein, Anthony S.
    Stein, Eytan M.
    Fathi, Amir T.
    Frankfurt, Olga
    Schuh, Andre C.
    Dohner, Hartmut
    Martinelli, Giovanni
    Patel, Prapti A.
    Raffoux, Emmanuel
    Tan, Peter
    Zeidan, Amer M.
    De Botton, Stephane
    Stone, Richard M.
    Frattini, Mark
    Franovic, Aleksandra
    Xu, Emily
    Winkler, Thomas
    Wu, Bin
    Vyas, Paresh
    BLOOD, 2020, 136
  • [32] Clinical Efficacy of Sorafenib in Patients with Acute Myeloid Leukemia (AML) and Activating FLT3-Mutations
    Schroeder, Thomas
    Saure, Chris-tian
    Bruns, Ingmar
    Zohren, Fabian
    Czibere, Akos G.
    Safaian, Nelly Nancy
    Fenk, Roland
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2009, 114 (22) : 812 - 812
  • [33] MOLECULAR GENETIC TESTING PATTERNS FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) ENROLLED IN THE CONNECT® MDS/AML DISEASE REGISTRY
    Pollyea, D.
    George, T.
    Foucar, K.
    Erba, H.
    Thompson, M.
    Roboz, G.
    Landau, D.
    Pagel, J.
    Seiter, K.
    Cogle, C.
    Nifenecker, M.
    Swern, A.
    Kiselev, P.
    Sugrue, M.
    HAEMATOLOGICA, 2017, 102 : 379 - 379
  • [34] Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia
    Bewersdorf, Jan Philipp
    Patel, Kishan K.
    Shallis, Rory M.
    Podoltsev, Nikolai A.
    Kewan, Tariq
    Stempel, Jessica
    Mendez, Lourdes
    Stahl, Maximilian
    Stein, Eytan M.
    Huntington, Scott F.
    Goshua, George
    Zeidan, Amer M.
    LEUKEMIA & LYMPHOMA, 2024, 65 (08) : 1136 - 1144
  • [35] Outpatient-Based Low-intensity Induction With Sorafenib in FLT3-ITD-Mutated Newly Diagnosed Acute Myeloid Leukemia (AML)
    Baskarane, Hemavathi
    Sahoo, Ranjit Kumar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S292 - S293
  • [36] Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry
    Pollyea, Daniel A.
    George, Tracy I.
    Abedi, Mehrdad
    Bejar, Rafael
    Cogle, Christopher R.
    Foucar, Kathryn
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Maciejewski, Jaroslaw P.
    Revicki, Dennis A.
    Roboz, Gail J.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Thompson, Michael A.
    Kurtin, Sandra E.
    Louis, Chrystal U.
    Nifenecker, Melissa
    Flick, E. Dawn
    Swern, Arlene S.
    Kiselev, Pavel
    Steensma, David P.
    Erba, Harry P.
    EJHAEM, 2020, 1 (01): : 58 - 68
  • [37] Survival and Outcomes after Relapse in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Treated with Venetoclax-Based Chemotherapy
    Chow, Lydia D.
    Chen, Denaly
    Vergara-Lluri, Maria E.
    Tam, Eric
    Woan, Karrune
    Chaudhary, Preet M.
    Yaghmour, George
    Ladha, Abdullah
    BLOOD, 2022, 140 : 9027 - 9028
  • [38] Updated Results of a Randomized Phase II Trial of Idarubicin and Cytarabine with Clofarabine or Fludarabine in Patients with Newly Diagnosed Acute Myeloid Leukemia
    Short, Nicholas J.
    Ravandi, Farhad
    Huang, Xuelin
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Daver, Naval
    Khouri, Rita B.
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    Wierda, William G.
    DiNardo, Courtney D.
    O'Brien, Susan M.
    Shah, Syed
    Pike, Allison
    Brandt, Mark
    Kantarjian, Hagop M.
    Jabbour, Elias J.
    BLOOD, 2016, 128 (22)
  • [39] Phase II Study of the Combination of Clofarabine Plus Idarubicin and Cytarabine (CIA) In Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Naqvi, Kiran
    Ravandi, Farhad
    Kantarjian, Hagop
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Thomas, Deborah A.
    Koller, Charles Asa
    Konopleva, Marina
    Byrd, Anna
    Kwari, Monica
    Faderl, Stefan
    BLOOD, 2010, 116 (21) : 464 - 465
  • [40] Timing of response with venetoclax combination treatment in patients with newly diagnosed acute myeloid leukemia
    Jonas, Brian A.
    Wei, Andrew H.
    Recher, Christian
    DiNardo, Courtney D.
    Jang, Jun-Ho
    Pratz, Keith
    Panayiotidis, Panayiotis
    Montesinos, Pau
    Yeh, Su-Peng
    Ivanov, Vladimir
    Fiedler, Walter
    Yamauchi, Takahiro
    Duan, Yinghui
    Mendes, Wellington
    Potluri, Jalaja
    Tews, Bjorn
    Ofran, Yishai
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : E299 - E303
12345